Company intelligence / Profile preview

HumanCells Biosciences

Ownership: Private
Development stage: Other

Overview

HumanCells Biosciences is a biotechnology company specializing in the provision of high-quality human and non-human primate blood and primary immune cells, such as PBMCs, T cells, B cells, monocytes, NK cells, and CD34+ stem cells, for research and drug discovery applications. The company focuses on the supply of biological materials rather than direct clinical development[1][2][5].

Industry: Drug Discovery Services

Beyond the preview

Go deeper on HumanCells Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HumanCells Biosciences.